tiprankstipranks
Newron Pharmaceuticals SpA (NWPHF)
OTHER OTC:NWPHF
US Market
NWPHF
Newron Pharmaceuticals SpA
RESEARCH TOOLSreports
Want to see NWPHF full AI Analyst Report?

Newron Pharmaceuticals SpA (NWPHF) Income Statement

12 Followers

Newron Pharmaceuticals SpA Income Statement

Last quarter (Q4 2025), Newron Pharmaceuticals SpA's total revenue was €7.24M, an increase of 103.20% from the same quarter last year. In Q4, Newron Pharmaceuticals SpA's net income was €-13.19M. See Newron Pharmaceuticals SpA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
€ 19.13M€ 51.39M€ 9.06M€ 6.09M€ 5.76M
Gross Profit
€ 19.13M€ 51.39M€ 9.06M€ 6.09M€ 5.76M
Operating Expenses
€ 23.81M€ 25.22M€ 20.69M€ 19.40M€ 18.12M
Depreciation and Amortization
€ 173.12K€ 192.00K€ 201.00K€ 202.00K€ 47.00K
EBITDA
€ -4.55M€ 25.94M€ -11.83M€ -13.32M€ -11.92M
Operating Income
€ -4.70M€ 26.17M€ -11.63M€ -13.30M€ -12.36M
Other Income/Expenses
€ -7.66M€ -4.78M€ -4.57M€ -4.17M€ -2.53M
Pretax Income
€ -12.35M€ 21.39M€ -16.20M€ -17.47M€ -14.88M
Net Income
€ -13.33M€ 15.84M€ -16.22M€ -17.49M€ -14.90M
Per Share Metrics
Basic EPS
€ -0.67€ 0.85€ -0.91€ -0.98€ -0.84
Diluted EPS
€ -0.67€ 0.85€ -0.91€ -0.98€ -0.84
Weighted Average Shares Outstanding
 19.96M 18.56M 17.84M 17.84M 17.84M
Weighted Average Shares Outstanding (Diluted)
 19.96M 18.56M 17.84M 17.84M 17.84M
Currency in EUR

Newron Pharmaceuticals SpA Earnings and Revenue History